1832 Asset Management L.P. trimmed its position in Astera Labs, Inc. (NASDAQ:ALAB - Free Report) by 71.3% in the first quarter, according to its most recent filing with the SEC. The fund owned 613,900 shares of the company's stock after selling 1,527,300 shares during the period. 1832 Asset Management L.P. owned 0.37% of Astera Labs worth $36,631,000 as of its most recent filing with the SEC.
Other hedge funds and other institutional investors have also bought and sold shares of the company. Sound Income Strategies LLC raised its position in Astera Labs by 34.7% during the 1st quarter. Sound Income Strategies LLC now owns 792 shares of the company's stock worth $47,000 after purchasing an additional 204 shares during the last quarter. GAMMA Investing LLC increased its position in Astera Labs by 55.7% during the 1st quarter. GAMMA Investing LLC now owns 794 shares of the company's stock valued at $47,000 after purchasing an additional 284 shares during the period. Harbour Investments Inc. raised its holdings in Astera Labs by 351.7% during the 1st quarter. Harbour Investments Inc. now owns 795 shares of the company's stock worth $47,000 after purchasing an additional 619 shares during the last quarter. Migdal Insurance & Financial Holdings Ltd. acquired a new position in shares of Astera Labs in the 1st quarter worth approximately $48,000. Finally, Hazlett Burt & Watson Inc. increased its position in shares of Astera Labs by 1,670.0% during the first quarter. Hazlett Burt & Watson Inc. now owns 885 shares of the company's stock worth $53,000 after buying an additional 835 shares during the period. Institutional investors own 60.47% of the company's stock.
Insider Activity
In other Astera Labs news, COO Sanjay Gajendra sold 280,000 shares of the firm's stock in a transaction dated Thursday, August 7th. The stock was sold at an average price of $170.02, for a total value of $47,605,600.00. Following the sale, the chief operating officer owned 5,525,545 shares of the company's stock, valued at $939,453,160.90. This trade represents a 4.82% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, CFO Michael Truett Tate sold 500,000 shares of the firm's stock in a transaction that occurred on Friday, May 30th. The shares were sold at an average price of $90.23, for a total transaction of $45,115,000.00. Following the completion of the sale, the chief financial officer directly owned 618,996 shares in the company, valued at $55,852,009.08. This represents a 44.68% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 2,205,616 shares of company stock worth $280,372,731. 12.50% of the stock is owned by corporate insiders.
Astera Labs Stock Performance
Shares of Astera Labs stock traded up $9.95 during mid-day trading on Thursday, hitting $189.15. 4,541,932 shares of the stock were exchanged, compared to its average volume of 4,933,212. Astera Labs, Inc. has a 12 month low of $36.85 and a 12 month high of $199.47. The company has a 50-day simple moving average of $128.86 and a 200 day simple moving average of $94.43. The company has a market capitalization of $31.44 billion, a P/E ratio of 337.77, a P/E/G ratio of 4.53 and a beta of 1.39.
Astera Labs (NASDAQ:ALAB - Get Free Report) last issued its quarterly earnings results on Tuesday, August 5th. The company reported $0.44 EPS for the quarter, topping analysts' consensus estimates of $0.33 by $0.11. The business had revenue of $191.93 million for the quarter, compared to analyst estimates of $172.46 million. Astera Labs had a return on equity of 9.53% and a net margin of 16.54%.Astera Labs's quarterly revenue was up 149.5% compared to the same quarter last year. During the same period last year, the company posted $0.13 earnings per share. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. Analysts predict that Astera Labs, Inc. will post 0.34 EPS for the current year.
Analysts Set New Price Targets
A number of analysts have weighed in on ALAB shares. Northland Securities downgraded Astera Labs from an "outperform" rating to a "market perform" rating and set a $120.00 price target for the company. in a report on Tuesday, July 22nd. Northland Capmk lowered Astera Labs from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, July 22nd. Morgan Stanley lifted their price objective on shares of Astera Labs from $125.00 to $155.00 and gave the company an "overweight" rating in a research note on Wednesday, August 6th. Zacks Research raised shares of Astera Labs to a "strong-buy" rating in a research note on Tuesday, August 12th. Finally, Susquehanna lifted their price target on shares of Astera Labs from $80.00 to $125.00 and gave the company a "neutral" rating in a research note on Thursday, August 7th. One investment analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat, Astera Labs presently has a consensus rating of "Moderate Buy" and a consensus price target of $129.13.
Check Out Our Latest Stock Analysis on ALAB
Astera Labs Company Profile
(
Free Report)
Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.
Read More

Before you consider Astera Labs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Astera Labs wasn't on the list.
While Astera Labs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.